Abstract
In the process of DNA replication, the first steps in restoring the chromatin landscape involve parental histone recycling and new histone deposition. Disrupting histone recycling to either the leading or lagging strand induces asymmetric histone inheritance, affecting epigenome maintenance and cellular identity. However, the order and kinetics of these effects remain elusive. Here, we use inducible mutants to dissect the early and late consequences of impaired histone recycling. Simultaneous disruption of both leading (POLE4) and lagging strand (MCM2-2A) recycling pathways impairs the transmission of parental histones to newly synthesized DNA, releasing some parental histones to the soluble pool. Subsequently, H3K27me3 accumulates aberrantly during chromatin restoration in a manner preceding gene expression changes. Loss of histone inheritance and the ensuing chromatin restoration defects alter gene expression in embryonic stem cells and challenge differentiation programs and cell viability. Our findings demonstrate the importance of efficient transmission of histone-based information during DNA replication for maintaining chromatin landscapes, differentiation potential, and cellular viability.
Originalsprog | Engelsk |
---|---|
Artikelnummer | eadr1453 |
Tidsskrift | Science Advances |
Vol/bind | 11 |
Udgave nummer | 8 |
Antal sider | 15 |
ISSN | 2375-2548 |
DOI | |
Status | Udgivet - 2025 |
Bibliografisk note
Funding Information:We would like to thank the entire Groth laboratory for fruitful discussions, D. Mayer for discussion on the differentiation experiments, S. Boulton for sharing POLE4 antibodies, N. Mailand lab for sharing antibodies, M. Michaut, H. Wollmann, and A. Kalvisa from the CPR/ReNew Genomics Platform for technical support, support, and use of instruments, and G. de la Cruz and the reNEW Flow Cytometry Platform for technical expertise, support, and use of instruments. Research in the Groth lab is supported by The Lundbeck Foundation Post-doc fellowship R402-2022-1502 (F.J.), the European Research Council grant ERC CoG 724436 (A.G.), the Novo Nordisk Foundation NNF21OC0067425 (A.G.), the Novo Nordisk Foundation_ NNF23OC0086482 (A.G.), Independent Research Fund Denmark (Danmarks Frie Forskninsfond, DFF) 7079-00005B (A.G.), Danish Cancer Society KBVU-BK project R352-A20669 (A.G.), and Independent Research Fund Denmark (Danmarks Frie Forskninsfond, DFF) 3101-00149B (A.G.). Research at CPR is supported by the Novo Nordisk Foundation NNF14CC0001.
Publisher Copyright:
Copyright © 2025 The Authors, some rights reserved.